Cargando…
The protective effect of the spleen in sickle cell patients. A comparative study between patients with asplenia/hyposplenism and hypersplenism
Sickle cell disease (SCD) is caused by a point mutation in the beta-globin gene. SCD is characterized by chronic hemolytic anemia, vaso-occlusive events leading to tissue ischemia, and progressive organ failure. Chronic inflammatory state is part of the pathophysiology of SCD. Patients with SCD have...
Autores principales: | Peretz, Sari, Livshits, Leonid, Pretorius, Etheresia, Makhro, Asya, Bogdanova, Anna, Gassmann, Max, Koren, Ariel, Levin, Carina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465245/ https://www.ncbi.nlm.nih.gov/pubmed/36105295 http://dx.doi.org/10.3389/fphys.2022.796837 |
Ejemplares similares
-
PB2222: THE PROTECTIVE EFFECT OF THE SPLEEN IN SICKLE CELL PATIENTS. A COMPARATIVE STUDY BETWEEN PATIENTS WITH ASPLENIA AND HYPERSPLENISM.
por: Peretz, S., et al.
Publicado: (2022) -
Back to the “Gold Standard”: How Precise is Hematocrit Detection Today?
por: Livshits, Leonid, et al.
Publicado: (2022) -
5613260 A PHASE -- IIA-IIB, OPEN LABEL, SINGLE CENTER TRIAL TO STUDY SAFETY, TOLERABILITY AND EFFICACY OF MEMANTINE AS SUPPORTIVE LONG-TERM TREATMENT OF SICKLE CELL PATIENTS: TRIAL DESIGN AND ENROLLMENT
por: Levin, C.L., et al.
Publicado: (2023) -
The Impact of Ca(2+) on Intracellular Distribution of Hemoglobin in Human Erythrocytes
por: Livshits, Leonid, et al.
Publicado: (2023) -
MEMSID: Results From a Phase 2 Pilot Study on Memantine Treatment for Sickle Cell Disease
por: Hegemann, Inga, et al.
Publicado: (2020)